Pharm Exec spent the year speaking with some of the most interesting professionals from the life sciences industry.
Q&A: How Does a ‘Never Enough’ Achievement Culture Impact Your Workforce’s Morale? Planning for 2024 With Journalist and Author Jennifer Breheny Wallace
Jennifer Breheny Wallace, award-winning journalist and author, notes that C-Suite leaders should understand the financial risks of not taking action to address workplace burnout in 2024.
Reacting to Trends: Q&A With Leslie Orne, CEO of Trinity Life Sciences
Orne discusses the forces impacting the life sciences market and how companies are reacting.
Q&A With Kevin O'Neill, president and CEO of GE HealthCare, Pharmaceutical Diagnostics
O'Neill discusses the company's place in the global market and recent advancements to improve the patient experience.
The Changing Prescriber Communications Dynamic: Q&A with Caleb Costa, Chief Customer Officer at InCrowd
Explore the changing dynamics of healthcare professionals' communication preferences in a post-pandemic world, as Pharm Exec's Fran Pollaro has a no frills discussion about InCrowd's latest insights with chief customer officer Caleb Costa.
Threads, the Twitter Competitor's Impact on Pharma Marketing: Q&A with Justin Chase
An insightful discussion about how Meta's newest social media platform, Threads, is quickly adding another facet to the digital landscape for pharma marketers.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.